Author + information
- Received October 18, 2005
- Revision received February 8, 2006
- Accepted February 14, 2006
- Published online June 20, 2006.
- Matthew R. Reynolds, MD, MSc⁎,⁎ (, )
- David J. Cohen, MD, MSc⁎,
- Aaron D. Kugelmass, MD†,
- Phillip P. Brown, MD‡,
- Edmund R. Becker, PhD§,
- Steven D. Culler, PhD§ and
- April W. Simon, MSN∥
- ↵⁎Reprint requests and correspondence:
Dr. Matthew R. Reynolds, Division of Cardiology, Baker 4, Beth Israel Deaconess Medical Center, 185 Pilgrim Road, Boston, Massachusetts 02215.
Objectives We aimed to quantify the frequency and nature of early complications after implantable cardioverter-defibrillator (ICD) implantation in general practice, and estimate the incremental costs of those complications to the health care system.
Background Cardioverter-defibrillator implantation rates are rising quickly. Little has been published regarding the outcomes and costs of these procedures in unselected populations.
Methods Using Medicare Provider Analysis and Review (MedPAR) files, we identified 30,984 admissions containing procedure codes for new ICD or cardiac resynchronization therapy defibrillator implantation in fiscal year 2003. The frequencies of eight complicating diagnoses during these admissions were determined. Length of stay (LOS) and total hospital costs, derived using whole-hospital cost to charge ratios, were calculated for each admission. The incremental effects of any and each complication on LOS and hospital cost were estimated in multivariable models, adjusting for demographic factors and comorbid conditions.
Results The mean cost for all admissions was $42,184 (median $37,902) with mean LOS of 4.7 days (median 2.0 days). One or more complications were coded in 10.8% of admissions, most commonly “mechanical complication of the ICD” and hemorrhage/hematoma. The occurrence of any complication increased adjusted LOS by 3.4 days and costs by $7,251. Each of the individual complications was associated with highly significant increases in both LOS (1 to 10 days) and hospital cost ($5,000 to $20,000).
Conclusions In fiscal 2003, 10.8% of Medicare patients undergoing cardioverter-defibrillator implantation experienced one or more early complications, associated with significant increases in LOS and costs. Efforts to reduce these complications could have significant clinical and financial benefits.
- Received October 18, 2005.
- Revision received February 8, 2006.
- Accepted February 14, 2006.
- American College of Cardiology Foundation